$542 Million is the total value of Atlas Venture Advisors, Inc.'s 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DKNG | DRAFTKINGS INC | $446,728,000 | +31.7% | 7,284,008 | 0.0% | 82.49% | +8.5% | |
TBIO | Sell | TRANSLATE BIO INC | $30,871,000 | -36.9% | 1,872,115 | -29.5% | 5.70% | -48.1% |
ROKU | ROKU INC | $18,799,000 | -1.9% | 57,707 | 0.0% | 3.47% | -19.2% | |
BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $18,301,000 | +66.4% | 612,696 | 0.0% | 3.38% | +37.0% | |
SNAP | SNAP INCcl a | $12,841,000 | +4.4% | 245,559 | 0.0% | 2.37% | -14.0% | |
FSTX | F-STAR THERAPEUTICS INC | $6,227,000 | +9.7% | 574,996 | 0.0% | 1.15% | -9.7% | |
LRMR | LARIMAR THERAPEUTICS INC | $4,269,000 | -31.8% | 292,184 | 0.0% | 0.79% | -43.8% | |
VRDN | VIRIDIAN THERAPEUTICS INC | $3,501,000 | +1.6% | 209,505 | 0.0% | 0.65% | -16.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SNAP INC | 20 | Q3 2023 | 6.1% |
ROKU INC | 16 | Q3 2023 | 11.7% |
LARIMAR THERAPEUTICS INC | 14 | Q3 2023 | 1.4% |
TRANSLATE BIO INC | 11 | Q2 2021 | 52.9% |
INTEGRAL AD SCIENCE HLDNG CO | 10 | Q3 2023 | 71.2% |
BICYCLE THERAPEUTICS PLC | 10 | Q3 2021 | 25.2% |
VIRIDIAN THERAPEUTICS INC | 10 | Q1 2023 | 2.1% |
F-STAR THERAPEUTICS INC | 9 | Q4 2022 | 1.3% |
DRAFTKINGS INC | 8 | Q1 2022 | 82.5% |
MIRAGEN THERAPEUTICS INC | 8 | Q3 2020 | 5.0% |
View Atlas Venture Advisors, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-02 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-08 |
13F-HR | 2023-01-31 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-01-27 |
13F-HR | 2021-11-04 |
View Atlas Venture Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.